Yeah, okay, Michael, great question. Uh I I will tell you I will give you a little color, just recognize it's day three for me officially, so I'm gonna try to give you a little a little a little more context for how the brands are doing. I I I will tell you your your overall question, I I I and I I think I said this a little bit earlier, uh a lot of the challenges that they've had over the past few years have been in my mind, 100% executional. And I I don't think I found any that I perceive as being structural yet, right? And and so and and so I and but I do what I will say is um I think Kirk and the leadership team at Kenview did a phenomenal job pivoting when Kirk got in that chair. And I and I think this is goes back to it, and this is where Kirk and I bonded because we were kind of trained by the same people, uh, and so we have a similar philosophy on on how you support brands. And and so ? I think Kirk made a lot of big moves to strengthen the execution. One of the most important was at the beginning of January he flipped the operating model which matches almost exactly with ours, uh which is why we've been able ? to so seamlessly move to the new work structure org structure on Monday first thing and we're operating in the new model. Um I I will tell you I'm encouraged with uh Ken View's Q three performance as you you guys probably saw organic was up about three ? and we're seeing some positive momentum. Um, I I think there is plenty moving in the right direction. Um, and and maybe I'll note a few things, Michael. You know, OTC overall, you know, I think is is performing well in in my book. Uh Tylenol for the year, I think up somewhere between low to mid single digit, I think, which is a great rebound. I think in the quarter it was up about 70 bips of share. ? Uh also in OTC, Nick Rett is up about 7% year to date, Zertec up five percent year to date. Love the advertising they're doing to drive kind of category expansion ? uh with Sanjay Battiya. And then and then um I I would say overall hair very good. Rogain, uh I surprisingly I didn't know this Michael, ? but um you know it may be driven by some GLP adoption, GLP one adoption. So Rogain's up thirty percent year to date. OGX uh the shampoo is also uh performing very well. And then in Essential Care, ? you know the baby brands are up about five year to date. Band-Aid, uh, which is a great high Halloween giveaway, uh, is up four uh percent year to date. And so I think I think there is plenty moving in the right direction. I again, what's driving it, and and this kind of reflects maybe a personnel choice I made more recently. ? You know, North America it's clear, you know, Carlos and I also have very similar training, and he's very focused on on the core aspects of execution, which in you know, dis DPSM is the shorthand, which is distribution pricing, shelving, and merchandising, and and focusing on execution, which I think, Michael, have been, you know, a little bit off of the focus area uh for KenView in the past. And I think we are seeing really, you know, that kind of performance is really driven by you know better fundamental execution across all those levers. I think we're not out of the woods yet, and so the the areas that we gotta improve, you know, I would say they're stabilizing, but there's plenty of work left to be done. Skin care was down just a little bit under a point uh year to date, you know, and and that's versus a category that's up about four. Um and again, I think the team has taken steps to improve execution there. I think medium term, and this is my perspective, and still needs to be worked through the team. Um I I think it's about resetting the assortment. I do think you know there's some extensions that we've done with some of the brands that uh you know will require a reset reset over time and and uh ? you know the other area for me and John Halverson knows this and he's gonna he's uh totally up to the task and I was just with him ? and uh the agencies a couple we've got to improve the creative execution and and I and I'm looking you know while you know in skincare the the marketing investment is fine and it's competitive with the category I think there's room to to increase our investment there. ? And then the other area is oral care. Liz Terene, uh you're to date down about two points. you know, for me, and this is my opinion, uh, which is I I think we need to simplify and clarify the offering and the key benefits for the consumer. Um, given the leadership share position that we have, I mean, you know, you know, very, very strong leadership position in the category. You know, for me, it should be similar to what we've been doing with Kleenex and DePen and Poise, which ? is focus advertising on expanding penetration frequency of the category. And so that's kind of the ? you know the focus area for ? us. You ? know, beyond that, Michael, I I would say longer term, there's a lot more headroom in these categories than I originally thought when ? we we made the initial announcement. Um, you know, it's going to take some time to get there. We're not going to take shortcuts. ? You know, we will build through the fundamentals. And so what you'll probably see in 27 ? is a little bit of a conservative approach that we reflected in our 2027-28 outlook. You know, we're we want to create the room to accelerate investments and get the brands in a better position to
Passages & reports (47) 21:07 Yeah, okay, Michael, great question. Uh I I will tell you I will give you a little color, … Report 21:21 overall question, I I I and I I think I said this a little bit earlier, uh a lot of the ch… Report 21:37 so and and so I and but I do what I will say is um I think Kirk and the leadership team at… Report 21:52 we were kind of trained by the same people, uh, and so we have a similar philosophy on on … Report 21:59 I Report 22:00 think Kirk made a lot of big moves to strengthen the execution. One of the most important … Report 22:13 to Report 22:13 so seamlessly move to the new work structure org structure on Monday first thing and we're… Report 22:28 and Report 22:28 we're seeing some positive momentum. Um, I I think there is plenty moving in the right dir… Report 22:47 mid single digit, I think, which is a great rebound. I think in the quarter it was up abou… Report 22:54 Uh Report 22:55 also in OTC, Nick Rett is up about 7% year to date, Zertec up five percent year to date. L… Report 23:05 uh Report 23:05 with Sanjay Battiya. And then and then um I I would say overall hair very good. Rogain, uh… Report 23:15 but Report 23:15 um you know it may be driven by some GLP adoption, GLP one adoption. So Rogain's up thirty… Report 23:27 you know Report 23:28 the baby brands are up about five year to date. Band-Aid, uh, which is a great high Hallow… Report 23:46 personnel choice I made more recently. Report 23:48 You Report 23:48 know, North America it's clear, you know, Carlos and I also have very similar training, an… Report 24:08 you know, a little bit off of the focus area uh for KenView in the past. And I think we ar… Report 24:25 areas that we gotta improve, you know, I would say they're stabilizing, but there's plenty… Report 24:42 has taken steps to improve execution there. I think medium term, and this is my perspectiv… Report 24:59 require a reset reset over time and and uh Report 25:01 you know Report 25:02 the other area for me and John Halverson knows this and he's gonna he's uh totally up to t… Report 25:08 and uh Report 25:08 the agencies a couple we've got to improve the creative execution and and I and I'm lookin… Report 25:23 And Report 25:24 then the other area is oral care. Liz Terene, uh you're to date down about two points. you… Report 25:43 have, I mean, you know, you know, very, very strong leadership position in the category. Y… Report 25:54 is Report 25:54 focus advertising on expanding penetration frequency of the category. And so that's kind o… Report 25:59 you Report 26:00 know the focus area for Report 26:01 us. Report 26:02 You Report 26:02 know, Report 26:02 beyond that, Michael, I I would say longer term, there's a lot more headroom in these cate… Report 26:08 we Report 26:09 we made the initial announcement. Um, you know, it's going to take some time to get there.… Report 26:15 You Report 26:15 know, we will build through the fundamentals. And so what you'll probably see in 27 Report 26:20 is Report 26:20 a little bit of a conservative approach that we reflected in our 2027-28 outlook. You know… Report